Corium International (CORI) Priced

Commercial-stage pharmaceutical company focused on transdermal drug delivery.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $3.83 0.00 (0.0%)
First Day Return 0.0%
Return from IPO -52.1%
 
Corium International IPO News more
  • .
IPO Data
IPO File Date 03/03/2014
Offer Price $8.00
Price Range $10.00 - $12.00
Offer Shares (mm) 6.5
Deal Size ($mm) 52
 
IPO Data
IPO Date 04/02/2014
Offer Price $8.00
Price Range $10.00 - $12.00
Offer Shares (mm) 6.5
Deal Size ($mm) $52
 
Underwriters
more
Business Overview
Commercial-stage pharmaceutical company focused on transdermal drug delivery.
Commercial-stage pharmaceutical company focused on transdermal drug delivery.
more
Company Data
Headquarters Menlo Park, CA
Founded 1995
Employees 243
Website www.coriumgroup.com
 

Performance vs. IPO Index (IPOUSA)